ArticlePharmacoepidemiology and drug safety2025

Proton Pump Inhibitor Use Exceeding the U.S. Food and Drug Administration Approved Treatment Duration for Patients With Peptic Ulcer Disease: A Retrospective Cohort Study.

Jordan A Villars et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.